Colour enhancement - PsychonautWiki
Open main menu

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
25C-NBOH
ETH-LAD
Chameleon.jpgChameleon by Anonymous.
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
4-HO-MPT
Experience:25mg 3-MeO-PCP - Enhanced film experience
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Bufotenin
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
DMT
2C-D
MDEA
Ayahuasca
EPT
Tree.jpgJapanese Garden by Anonymous
Experience:3-MeO-PCP - Extreme psychosis
25I-NBOH
Bromo-DragonFLY
Allylescaline
25B-NBOH
5-MeO-DiPT
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
Experience:40mg - Brothermind and the Forest's Hand
MDAI
2C-T-2
3C-E
Psilocybin mushrooms
DPT
Oxiracetam
AL-LAD
MET
Experience:120mg - Garden of The Gods
Piracetam
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
ALD-52
DET
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
MDA
Omberacetam
Experience:1000 Morning Glory seeds - Rediscovering the Self
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
4-HO-DiPT
5-MeO-DALT
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
GABAergic hallucinogens
Enhancement of colour rose.jpgRose by Chelsea Morgan
LSZ
LSA
4-HO-DET
Experience:BK-2C-B - Various experiences
5F-PB-22
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Psilocin
DOC
25D-NBOMe
6-APB
PARGY-LAD
LSM-775
25C-NBOMe
3-MMC
MiPT
Experience:800 seeds LSA - My First Trip Ever
4-AcO-DiPT
DOI
Proscaline
4-HO-EPT
1B-LSD
PRO-LAD
2C-P
2C-I
25I-NBOMe
Experience:1mg 25c-NBOMe - Experiment in my room
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Pregabalin
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
Paradise island by Xanny.jpgParadise island by Subsentience
1P-ETH-LAD
Βk-2C-B
Efavirenz
2C-B
LSD
DOB
25N-NBOMe
5-Hydroxytryptophan
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
2C-E
JWH-073
Experience:4-HO-MiPT / A care free psychedelic getaway
TMA-6
25B-NBOMe
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
4-FA
2C-H
2C-T-21
4-AcO-DET
MiPLA
Memantine
THJ-2201
Phenethylamine (compound)
JWH-018
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
Phenylpiracetam
DiPT
Cannabis
6-APDB
4-AcO-MET
MPT
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
MDMA
Experience:337mg DMT fumarate - A Day With DMT
Experience:2 tabs DOB - My DOB Nightmare
5-MeO-MiPT
Mescaline
Aniracetam
Chur City in Switzerland.jpgChur, Switzerland by Naps284
ΑMT
4-AcO-DMT
2C-C
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Methallylescaline
4-AcO-MiPT
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
4-HO-MiPT
4-HO-MET
Experience:300µg LSD - Togetherness and the Silent Dusk
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
THJ-018
3-MeO-PCE
Pramiracetam
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
2C-T-7
4-HO-DPT
1P-LSD
Experience:250mg DXM - DXM Itch and Trip Report
5-MeO-DiBF
Amanita muscaria
Experience:4.5g - The Grand Introduction to Beauty and Fear
Experience:4x 200ug tabs - You do not need to understand
2C-B-FLY
Ibogaine
Selective serotonin reuptake inhibitor
TMA-2
Escaline

Contents

Psychoactive substances

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.